Evotec to attend upcoming investor conferences
Hamburg, Germany, 03 September 2018:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting and attending the following conferences:
Goldman Sachs 8th Annual Biotech Symposium, London, UK
Date: Friday, 07 September 2018
Venue: London, UK
Attendee: Enno Spillner, Chief Financial Officer
J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK
Date: Wednesday, 12 September 2018
Venue: London, UK
Attendee: Enno Spillner, Chief Financial Officer
Morgan Stanley 16th Annual Global Healthcare Conference, New York, USA
Date: Thursday, 13 September, to Friday, 14 September 2018,
Presentation: 14 September 2018, 01.00 pm EDT (06.00 pm BST, 07.00 pm CEST)
Venue: New York, USA
Attendee: Dr Werner Lanthaler, Chief Executive Officer
Baader Investment Conference, Munich, Germany
Date: Monday, 24 September 2018, 02.00 pm CEST (01.00 pm BST, 08.00 am EDT)
Venue: Munich, Germany
Attendee: Enno Spillner, Chief Financial Officer
Berenberg and Goldman Sachs Seventh German Corporate Conference, Munich, Germany
Date: Wednesday, 26 September 2018, 02.30 pm CEST (01.30 pm BST, 08.30 am EDT)
Venue: Munich, Germany
Attendee: Dr Werner Lanthaler, Chief Executive Officer
Cantor Global Healthcare Conference 2018, New York, USA
Date: Monday, 01 October, to Tuesday, 02 October 2018,
Presentation: 02 October 2018, 08.35 am EDT (01.35 pm BST, 02.35 pm CEST)
Venue: New York, USA
Attendee: Enno Spillner, Chief Financial Officer
FORWARD LOOKING STATEMENTS
Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.